Nortech Systems (NSYS) earned $0.21 per diluted share in the third quarter on revenue of $33.05 million. A year earlier it lost $0.05 per share, so earnings grew 520.0% year over year. Revenue rose 8.4%. No consensus estimate or Earnings Whisper was available, so the quarter has to be judged on its own trajectory rather than against expectations. On that basis it was the best quarter of the year for profitability. The central tension is that the profit improvement is outrunning the top line. Margins, earnings and cash flow are improving, while revenue growth and near-term backlog are losing momentum.

The margin story is real. Gross profit rose 16.9% on 8.4% sales growth. Gross margin reached 17.8%, up from 17.0% in Q2 and 15.5% in Q1. Operating income climbed to $1.4 million, from $623 thousand in Q2 and $47 thousand in Q1. Trailing-twelve-month adjusted gross margin has now recovered to 16.8%, from a trough of 11.9% in early 2025.

The quality of the beat still deserves scrutiny. Three items flattered the quarter:

• **Incentive compensation reversal.** Management fully reversed $647 thousand of 2026 incentive compensation in the quarter. That is a large figure against $1.19 million of pre-tax income, and it implies internal targets will not be met.
• **Tariff recoveries.** IEEPA refunds reduced cost of goods sold by $153 thousand.
• **Tax line.** Part of the year-over-year swing to a profit reflects tax rather than operations. Last year's $818 thousand tax charge exceeded pre-tax income, and this quarter's effective rate was still elevated.

On a non-GAAP basis, adjusted EBITDA rose 56% to $1.96 million, excluding $236 thousand of strategy-review costs.

The top line tells a less comfortable story:

• **Growth is decelerating.** Revenue growth has slowed for three straight quarters, from 12.7% in Q1 to 9.3% in Q2 to 8.4% in Q3. Sales also dipped slightly from Q2's $33.5 million.
• **Near-term backlog fell.** The 90-day backlog dropped to $31.5 million from $33.4 million at June 30.
• **Total backlog stalled.** It was $92.8 million, essentially flat to slightly down from $93.8 million, after climbing steadily from $77.3 million at year-end.

The year-over-year backlog figure, up 20%, remains strong. The mix is constructive: aerospace and defense backlog is up 43% to $42.8 million, and industrial backlog is up roughly 70% to $21.2 million, both higher sequentially. Even so, industrial sales remain down year to date because of customer inventory adjustments and disruption from the Monterrey transfer.

China is the growth engine. Sales there jumped 56.5% to $8.2 million, roughly a quarter of the total and about 85% of year-to-date revenue growth. That concentration cuts both ways. Management flagged unfavorable customer and geographic mix as China grows faster. New Section 301 tariffs of roughly 10% to 12.5%, implemented in July, add another variable. A supplier quality issue is also raising costs, though management expects it to be resolved in the fourth quarter.

The most consequential new disclosure is the board's 2026 review of long-term strategy to evaluate opportunities to enhance shareholder value. The company said the review follows improvements in backlog, financial performance and bank financing. Costs reached $440 thousand year to date, and the release did not specify potential outcomes. Other forward-looking items include:

• new patents for a non-magnetic fiber optic connector for MRI environments and for in-cable diagnostics;
• a new SVP of Global Operations, focused on inventory and cash.

The CEO's tone was notably more confident; he said the company is "on a roll." No formal guidance was provided.

Cash flow improved meaningfully, though it leaned on customer prepayments:

• Year-to-date operating cash use narrowed to $275 thousand from $2.4 million at mid-year, implying about $2.1 million generated in Q3.
• Customer deposits rose $3.9 million year to date, an important contributor.
• Inventory grew $4.6 million, which helps explain management's emphasis on disciplined purchasing.
• Cash ended at $3.0 million plus $1.1 million restricted, against $8.3 million drawn on credit lines and a new term loan.

Market context is thin for this report. Investor sentiment readings, technical levels and a current price were not available. Shares opened at $15.44 after the August report, but the move since then cannot be assessed from the data provided. For now, the investment setup rests on the fundamentals and on how investors weigh the strategic review.

The bottom line is that Nortech delivered genuine margin and cash-flow progress and a clear swing to profitability. The headline flatters the underlying run rate, however, because of the incentive-compensation reversal, tariff refunds and tax effects. Meanwhile, revenue growth is slowing and backlog has stopped expanding sequentially. Bulls can point to a strong defense and industrial backlog and an open-ended strategic review. Bears have legitimate ammunition in the decelerating top line and a profit mix that leans on non-recurring help. Converting that $92.8 million backlog into shipments in Q4 is the test that matters.